Company Profile
AC Immune Stock Price, News & Analysis
- Ticker:
- ACIU
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, AC Immune is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
2.45 USD (-2.00%)
Close
Last updated: June 23, 2026 at 00:00
249.35M USD
Market cap
Why the stock is moving
ACIU is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
AC Immune is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, AC Immune is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
AC Immune follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, AC Immune sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of AC Immune (ACIU)?
AC Immune (ACIU) most recently closed at 2.45 USD, a -2.00% move versus the previous session.
What is the market cap of AC Immune (ACIU)?
AC Immune currently has a market capitalization of 249.35M USD on BioPharmSignal.
What does AC Immune do?
AC Immune is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is ACIU stock listed?
AC Immune (ACIU) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, AC Immune is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Immune?
AC Immune is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is AC Immune targeting with Immune?
AC Immune is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.